Filter articles using the following links

GenSight Biologics launches a capital increase of approximately €25 million by means of an accelerated bookbuilding process

BioEurope – Digital

4th Annual Gene Therapy for Rare Disorders Europe – Virtual

GenSight Biologics Reports Cash Position as of September 30, 2020 and Provides Operational Update

GenSight Biologics Appoints Elsy Boglioli to its Board of Directors

Cell & Gene Meeting on the Mesa – Virtual

EURETINA 2020 – Virtual

HealthTech Innovation Days (HTID®), Paris, France & Virtual Conference

Ophthalmology Futures Retina – Virtual Forum

Chardan 4th Annual Genetic Medicines Conference – Virtual